Repligen, a global, bioprocessing-focused life sciences company, provides innovative solutions for the advancement of biotherapeutic manufacturing. Experts in filtration, chromatography systems, process analytics, fluid management, and proteins, Repligen is a trusted partner serving the development and manufacture of a wide range of biologics, including cell and gene therapies, mRNA, monoclonal antibodies (mAbs), antibody–drug conjugates (ADCs), bispecific antibodies, and fusion proteins. Headquartered in Waltham, Massachusetts, USA, Repligen operates across 22 sites, including locations in the United States, Europe, and the Asia-Pacific region.
Looking for a particular Repligen Corporation employee's phone or email?
The Repligen Corporation annual revenue was $602.4 million in 2026.
James Bylund is the COO of Repligen Corporation.
1,061 people are employed at Repligen Corporation.
Repligen Corporation is based in Waltham, Massachusetts.
The NAICS codes for Repligen Corporation are [32, 3254, 325, 32541].
The SIC codes for Repligen Corporation are [28, 283].